Literature DB >> 18042890

The influence of p38 mitogen-activated protein kinase inhibitor on synthesis of inflammatory cytokine tumor necrosis factor alpha in spinal cord of rats with chronic constriction injury.

Li Xu1, Yuguang Huang, Xuerong Yu, Jianying Yue, Nan Yang, Pingping Zuo.   

Abstract

BACKGROUND: Tumor necrosis factor alpha (TNF-alpha) could trigger p38 mitogen-activated protein kinase (MAPK) activation. Conversely phosphorylated p38 (p-p38) could induce the upregulation of TNF-alpha. In this study, we examined the hypothesis that chronic constrictive injury (CCI) of the sciatic nerve could promote spinal cord release of TNF-alpha and produce allodynia via the p38 MAPK pathway.
METHODS: Sprague-Dawley rats were divided into five groups: 1) naïve control rats, 2) sham surgery rats, 3) CCI surgery rats without treatment, 4) CCI surgery rats with saline (0.9%) treatment, and 5) CCI surgery rats with the p38 MAPK inhibitor SB203580 treatment. In treatment groups, saline or SB203580 (2 microg, twice a day) was given intrathecally starting 1 day before or 1 day or 7 days after CCI. All rats were killed at different times after surgery to examine p38 MAPK activity and TNF-alpha levels in the spinal cord by Western blot analysis or immunohistochemistry. Mechanical allodynia was tested by a series of von Frey hairs 3, 7, and 14 days after surgery.
RESULTS: p-p38 MAPK was significantly increased at 3, 7, and 14 days after CCI surgery compared with time-matched shams (P < 0.05). Peripheral nerve injury induced mechanical allodynia and enhanced spinal concentrations of TNF-alpha (P < 0.05). Pretreatment or early treatment with SB203580 inhibited p38 MAPK activity, resulting in reduction of TNF-alpha synthesis and attenuation of mechanical allodynia (P < 0.05).
CONCLUSION: p38 MAPK activation is one aspect of the signaling cascade that culminates in TNF-alpha synthesis and contributes to mechanical allodynia after peripheral nerve injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042890     DOI: 10.1213/01.ane.0000287660.29297.7b

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  18 in total

1.  Chemokine CXCL13 activates p38 MAPK in the trigeminal ganglion after infraorbital nerve injury.

Authors:  Qian Zhang; Ming-Di Zhu; De-Li Cao; Xue-Qiang Bai; Yong-Jing Gao; Xiao-Bo Wu
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

2.  The ology of neuropathy: an integrative review of the role of neuroinflammation and TNF-α axonal transport in neuropathic pain.

Authors:  Robert R Myers; Veronica I Shubayev
Journal:  J Peripher Nerv Syst       Date:  2011-12       Impact factor: 3.494

3.  Suppression of microRNA-155 attenuates neuropathic pain by regulating SOCS1 signalling pathway.

Authors:  Yi Tan; Jun Yang; Kai Xiang; Qindong Tan; Qulian Guo
Journal:  Neurochem Res       Date:  2014-12-09       Impact factor: 3.996

4.  Inhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury.

Authors:  Wen-Sheng Qu; Dai-Shi Tian; Zhi-Bao Guo; Jun Fang; Qiang Zhang; Zhi-Yuan Yu; Min-Jie Xie; Hua-Qiu Zhang; Jia-Gao Lü; Wei Wang
Journal:  J Neuroinflammation       Date:  2012-07-23       Impact factor: 8.322

5.  Effect of Electroacupuncture on Activation of p38MAPK in Spinal Dorsal Horn in Rats with Complete Freund's Adjuvant-Induced Inflammatory Pain.

Authors:  Yi Liang; Jian-Qiao Fang; Jun-Ying Du; Jun-Fan Fang
Journal:  Evid Based Complement Alternat Med       Date:  2011-08-08       Impact factor: 2.629

6.  A disintegrin and metalloprotease 17 promotes microglial cell survival via epidermal growth factor receptor signalling following spinal cord injury.

Authors:  Zijian Wei; Deshui Yu; Yunlong Bi; Yang Cao
Journal:  Mol Med Rep       Date:  2015-02-27       Impact factor: 2.952

7.  Angiotensin II produces nociceptive behavior through spinal AT1 receptor-mediated p38 mitogen-activated protein kinase activation in mice.

Authors:  Wataru Nemoto; Osamu Nakagawasai; Fukie Yaoita; Syu-Ichi Kanno; Shin Yomogida; Masaaki Ishikawa; Takeshi Tadano; Koichi Tan-No
Journal:  Mol Pain       Date:  2013-07-31       Impact factor: 3.395

8.  An early granulocyte colony-stimulating factor treatment attenuates neuropathic pain through activation of mu opioid receptors on the injured nerve.

Authors:  Ming-Feng Liao; Shin-Rung Yeh; Ai-Lun Lo; Po-Kuan Chao; Yun-Lin Lee; Yu-Hui Hung; Kwok-Tung Lu; Long-Sun Ro
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

Review 9.  Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome.

Authors:  Jan M Keppel Hesselink; David J Kopsky
Journal:  J Pain Res       Date:  2015-10-23       Impact factor: 3.133

10.  Paeoniflorin and Albiflorin Attenuate Neuropathic Pain via MAPK Pathway in Chronic Constriction Injury Rats.

Authors:  Jianyu Zhou; Linyuan Wang; Jingxia Wang; Chun Wang; Zhihui Yang; Chenglong Wang; Yingli Zhu; Jianjun Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.